ID   GM01500
AC   CVCL_D870
SY   GM-1500; GM 1500; GM1500; GM01500B
DR   CLO; CLO_0031446
DR   Coriell; GM01500
DR   Wikidata; Q54836874
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3495441;
RX   PubMed=3893568;
RX   PubMed=7313555;
RX   PubMed=10936422;
CC   Problematic cell line: Misclassified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
CC   Population: Caucasian.
CC   Characteristics: Secretes IgG2 kappa (Coriell=GM01500).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
RX   CelloPub=CLPUB00447;
RA   Mulivor R.A., Suchy S.F.;
RT   "1992/1993 catalog of cell lines. NIGMS human genetic mutant cell
RT   repository. 16th edition. October 1992.";
RL   (In) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda (1992).
//
RX   DOI=10.1007/0-306-46877-8_4;
RA   Jernberg-Wiklund H., Nilsson K.;
RT   "Multiple myeloma cell lines.";
RL   (In) Human cell culture. Vol. 3. Cancer Cell Lines part 3; Masters J.R.W., Palsson B.O. (eds.); pp.81-155; Kluwer Academic Publishers; New York (2000).
//
RX   DOI=10.5962/bhl.title.4090;
RA   Coriell L.L., Greene A.E.;
RT   "The human genetic mutant cell repository: list of genetic variants,
RT   chromosomal aberrations and normal cell cultures submitted to the
RT   repository. 4th edition. October 1977.";
RL   (In) Institute for Medical Research (Camden, N.J.); pp.1-171; National Institutes of Health; Bethesda (1977).
//
RX   PubMed=3495441; DOI=10.1002/eji.1830170503;
RA   Kanowith-Klein S., Saxon A., Uittenbogaart C.H.;
RT   "Constitutive production of B cell differentiation factor-like
RT   activity by human T and B cell lines.";
RL   Eur. J. Immunol. 17:593-598(1987).
//
RX   PubMed=3893568; DOI=10.1182/blood.V66.2.444.444;
RA   Goldstein M., Hoxie J., Zembryki D., Matthews D., Levinson A.I.;
RT   "Phenotypic and functional analysis of B cell lines from patients with
RT   multiple myeloma.";
RL   Blood 66:444-446(1985).
//
RX   PubMed=7313555; DOI=10.1111/j.1365-3083.1981.tb00178.x;
RA   Simmons J.G., Fuller C.R., Buchanan P.D., Yount W.J.;
RT   "Distribution of surface, cytoplasmic and secreted IgG subclasses in
RT   human lymphoblastoid cell lines and normal peripheral blood
RT   lymphocytes.";
RL   Scand. J. Immunol. 14:1-13(1981).
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler H.G., Matsuo Y.;
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//